Cancer risk among users of neuroleptic medication: a population-based cohort study

Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46: 263–268

Baron JA (2003) Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog Exp Tumor Res 37: 1–24

Catts VS, Catts SV (2000) Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? Schizophr Res 41: 405–415

Dalton SO, Mellemkjær L, Thomassen L, Mortensen PB, Johansen C (2005) Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969–1993. Schizophr Res 75: 315–324

de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM (1995) Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry 152: 453–455

Dreyer L, Winther JF, Pukkala E, Andersen A (1997) Tobacco smoking. APMIS 105: 9–47

Dupont A, Møller Jensen O, Strömgren E, Jablensky A (1986) Incidence of cancer in patients diagnosed as schizophrenic in Denmark. In ten Horn GHMM, Giel R, Gulbinat W, Henderson JH (eds) Psychiatric Case Registries in Public Health. Amsterdam: Elsevier Science Publisherws, pp 229–239

Gaist D, Sorensen HT, Hallas J (1997) The Danish prescription registries. Dan Med Bull 44: 445–448

Gulbinat W, Dupont A, Jablensky A, Jensen OM, Marsella A, Nakane Y, Sartorius N (1992) Cancer incidence of schizoprenic patients. Results of record linkage studies in three countries. Br J Psychiatr 161 (Suppl 18): 75–85

Hait WN, Lazo JS (1986) Calmodulin: a potential target for cancer chemotherapeutic agents. J Clin Oncol 4: 994–1012

Halbreich U, Kinon BJ, Gilmore JA, Kahn LS (2003) Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology 28: Suppl 1: 53–67

Halbreich U, Shen J, Panaro V (1996) Are chronic psychiatric patients at increased risk for developing breast cancer? Am J Psychiatr 153: 559–560

Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA (1986) The prevalence of smoking among psychiatric outpatients. Am J Psychiatr 143: 993–997

Jones GRN (1985) Cancer therapy: phenothiazines in an unexpected role. Tumori 71: 563–569

Kanhouwa S, Gowdy JM, Solomon JD (1984) Phenothiazines and breast cancer. J Natl Med Ass 76: 785–788

Kelly JP, Rosenberg L, Palmer JR, Rao RS, Strom BL, Stolley PD, Zauber AG, Shapiro S (1999) Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines. Am J Epidemiol 150: 861–868

Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH (2000) Smoking and mental illness. A population-based prevalence study. JAMA 284: 2606–2610

Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, Lönnqvist J (2001) Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatr 58: 573–578

Mortensen PB (1987) Cancerdiagnostik og autopsifrekvens blandt skziofrene patienter. Ugeskr Laeger 149: 1973–1975

Mortensen PB (1989) The incidence of cancer in schizophrenic patients. J Epidemiol Commun Health 43: 43–47

Mortensen PB (1992) Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients. Acta Psychiatr Scand 85: 390–393

Mortensen PB (1994) The occurence of cancer in first admitted schizophrenic patients. Schizophr Res 12: 185–194

Munk-Joergensen P, Mortensen PB (1997) The Danish Psychiatric Central Register. Dan Med Bull 44: 82–84

Nakane Y, Ohta Y (1986) The example of linkage with a cancer register. In ten Horn GHMM, Giel R, Gulbinat W, Henderson JH (eds) Psychiatric Case Registries in Public Health. Amsterdam: Elsevier, pp 240–245

Nielsen GL, Sorensen HT, Zhou W, Steffensen FH, Olsen J (1997) The pharmacoepidemiologic prescription database of North Jutland – a valid tool in pharmacoepidemiological research. Int J Risk Safety Med 10: 203–205

Nordenberg J, Fenig E, Landau M, Weizman R, Weizman A (1999) Effects of psychotropic drugs on cell proliferation and differentiation. Biochem Phamacol 58: 1229–1236

O'Farrell TJ, Connors GJ, Upper D (1983) Addictive behaviors among hospitalized psychiatric patients. Add Behav 8: 329–333

Olivarius NF, Hollnagel H, Krasnik A, Pedersen PA, Thorsen H (1997) The Danish National Health Service Register. A tool for primary health care research. Dan Med Bull 44: 449–453

Overall JE (1978) Prior psychiatric treatment and the development of breast cancer. Arch Gen Psychiatr 35: 898–899

Potter JD (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst 91: 916–932

Schyve PM, Smithline F, Meltzer HY (1978) Neuroleptic-induced prolactin level elevation and breast cancer. An emerging issue. Arch Gen Psychiatr 35: 1291–1301

Storm HH, Michelsen E, Clemmensen IH, Pihl J (1997) The Danish Cancer Registry: history, content, quality and use. Dan Med Bull 44: 535–539

Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94: 252–266

Wagner S, Mantel N (1978) Breast cancer at a psychiatric hospital before and after the introduction of neuroleptic agents. Cancer Res 38: 2703–2708

Wang PS, Walker AM, Tsuang MT, Orav EJ, Glynn RJ, Levin R, Avorn J (2002) Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatr 59: 1147–1154